Nov 6 (Reuters) - Palla Pharma Ltd (PAL) :
- EXPECTS TO BE EBITDA POSITIVE FROM Q1 FY21
- EXPECTS NEGATIVE EBITDA PERFORMANCE FOR FY20
- NEGOTIATED EXTENSION OF WORKING CAPITAL DEBT FACILITY WITH WASHINGTON H. SOUL PATTINSON & CO LTD
- KEY TERMS OF AMENDED FACILITY INCLUDE TEMPORARY LIMIT INCREASE TO $20 MILLION
Nov 6 (Reuters) - Palla Pharma Ltd (PAL) : EXPECTS TO BE EBITDA...
Add to My Watchlist
What is My Watchlist?